• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Specialist James Denaro works on the floor of the New York Stock Exchange, Thursday, Jan. 3, 2019.
    Business

    Year ahead promises corporate America a gloomier replay of 2018

    Joe Williams -
    January 4, 2019 5:01 am
    0
    A sign outside Bristol-Myers Squibb offices in New Jersey. The pharmaceutical company reported a fourth-quarter loss after a $2.9 billion charge related to the GOP tax overhaul. (Christopher Barth/ Bloomberg News)
    Business

    Bristol-Myers buys Celgene for $74 billion amid growing drug-price scrutiny

    James Langford -
    January 3, 2019 10:08 am
    0
    Sen. Elizabeth Warren, D-Mass., gestures while speaking at the National Press Club in Washington, Tuesday, Aug. 21, 2018. Warren wants a lifetime ban on members of Congress from getting hired as lobbyists after they leave public office. She also wants to prohibit lawmakers from owning or trading individual stocks while in office.
    Beltway Confidential

    Don’t let Elizabeth Warren ruin the generic drug market

    Sally Pipes -
    December 31, 2018 4:34 pm
    0
    (Thinkstock Image)
    Business

    Federal judge blocks Trump rule cutting drug payments to hospitals

    Joe Williams -
    December 28, 2018 7:33 pm
    0
    Total revenues for Cigna in 2017 were $41.6 billion, an increase of 5 percent over 2016, driven by continued growth in Cigna's targeted customer segments.
    Business

    Cigna finalizes $67 billion merger with Express Scripts

    Joe Williams -
    December 20, 2018 7:08 pm
    0
    FILE - In this April 12, 2005 file photo, the world headquarters of Pfizer Inc. is shown in New York. In April, 2009, the FDA fired off warning letters to Pfizer Inc., GlaxoSmithKline and a dozen other drugmakers for search engine ads that violated federal rules.
    Healthcare

    Pfizer, GSK create consumer health powerhouse

    Kimberly Leonard -
    December 19, 2018 12:35 pm
    0
    Sen. Elizabeth Warren, D-Mass., gestures while speaking at the National Press Club in Washington, Tuesday, Aug. 21, 2018. Warren wants a lifetime ban on members of Congress from getting hired as lobbyists after they leave public office. She also wants to prohibit lawmakers from owning or trading individual stocks while in office.
    Editorials

    Elizabeth Warren’s silly drugmaking scheme

    Washington Examiner -
    December 19, 2018 5:00 am
    0
    Democratic candidate for U.S. Senate from Massachusetts, incumbent Elizabeth Warren speaks during a campaign event for Ohio Democratic gubernatorial candidate Richard Cordray, Thursday, Nov. 1, 2018, in Columbus, Ohio.
    Business

    Elizabeth Warren wants to turn the federal government into a generic drugmaker

    Joe Williams -
    December 18, 2018 3:27 pm
    0
    Oxycodone pills are displayed, Wednesday, Aug. 29, 2018, in New York.
    Healthcare

    Court orders release of opioid marketing records

    Kimberly Leonard -
    December 14, 2018 2:15 pm
    0
    Big Pharma’s likely defeat on ‘donut hole’ foreshadows treacherous 2019
    Business

    Big Pharma’s likely defeat on ‘donut hole’ foreshadows treacherous 2019

    Joe Williams -
    December 12, 2018 5:36 pm
    0
    1...686970...159Page 69 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.